- Patent Title: Substituted benzofuran compounds for the treatment of hepatitis C
-
Application No.: US15551006Application Date: 2016-02-17
-
Publication No.: US10570108B2Publication Date: 2020-02-25
- Inventor: Tao Wang , Zhiwei Yin , John F. Kadow
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- International Application: PCT/US2016/018184 WO 20160217
- International Announcement: WO2016/133972 WO 20160825
- Main IPC: C07D307/84
- IPC: C07D307/84 ; C07D405/12 ; C07D407/12 ; C07H7/06 ; C07F9/655
Abstract:
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV:
Public/Granted literature
- US20180030019A1 SUBSTITUTED BENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Public/Granted day:2018-02-01
Information query
